AkzoNobel

4Clinics is a Contract Research Organization (CRO) providing Data management, Biostatistics, Scientific Writing, Regulatory Affairs and Clinical Operations services for clinical and epidemiological studies with a particular expertise in vaccines, immunology, immuno-oncology and medical devices.

4Clinics serves pharmaceutical, biotechnology and medical devices companies as well as NGOs, hospitals and researchers with tailor-made services including remote biometry and medical writing platforms. 4Clinics has offices in Belgium, France, USA and Morocco and has a global coverage.

For more information, please visit www.4Clinics.com

54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.

A+ Science was founded in 1997 by dedicated researchers within the cardiovascular field and as a subsidiary to the University of Gothenburg, since then the company has delivered many great results to the world of research.

A+ Science is a unique Contract Research Organisation (CRO) run by its dedicated personnel. The company has long experience of services in clinical trials for pharmaceuticals (Phase I-IV) as well as medical devices. A+ Science also conducts non-interventional and registry trials.

Our core expertise is in the Nordic Countries, however through close collaboration with other CROs, we are also able to cover many other countries.

Our vision is to become the CRO best known for its unique and dedicated personnel with focus on customer satisfaction. To Earn Trust- Make Difference

As a member of ITOCHU Group, A2 Healthcare Corporation contributes to the research and development of medical and pharmaceutical products through sophisticated offering of clinical research full services with footprints in the US and Asia. In particular, A2 Healthcare specializes in early phase clinical trials, serving hundreds of clients in Taiwan (86%) and worldwide (14%).

Astrom Research International (ARI) is a CRO and specialised consultancy focusing exclusively on the Chinese market. We turn to Western companies in the Life Science sector intending to conduct clinical research or set up operations in China. We operate through a network of high quality local CROs and hospitals in all major Chinese cities and work cooperatively with key regulatory authorities on both provincial and national level.